Outcome of discontinuing bevacizumab prior to malignant glioma progression

Wendy J. Sherman, Jeffrey J. Raizer, Sean A. Grimm*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Outcome of discontinuing bevacizumab prior to malignant glioma progression'. Together they form a unique fingerprint.